An innovative backpack, incorporating aerospace technology, shows promise as a balance aid for patients with the movement disorder ataxia. Research conducted by Radboud university medical center, in ...
Dr. Mark Payne, a professor of pediatrics at the Indiana University School of Medicine and a pediatric cardiologist at Riley ...
Please provide your email address to receive an email when new articles are posted on . Approximately 5,000 people in the United States have Friedreich’s ataxia. Advocates virtually met with ...
Please provide your email address to receive an email when new articles are posted on . Vatiquinone inhibits 15-Lipoxygenase, which regulates the pathways that Friedreich’s ataxia disrupts. PTC ...
Hosted on MSN
Understanding ataxia from genes to daily life
Ataxia is more than just clumsiness—it’s a neurological condition that affects coordination, balance, speech, and even vision ...
Breakthrough Therapy designation based on interim clinical data from Phase I/II trials showing clinically meaningful improvements in cardiac biomarkers and functional measures LX2006 also selected for ...
(RTTNews) - Larimar Therapeutics, Inc. (LRMR) is trading sharply higher today, up over 30%, on news of the FDA granting Breakthrough Therapy Designation to Nomlabofusp for the treatment of adults and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results